REPLIGEN CORP (RGEN) Deferred Income Tax Expense (Benefit) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Repligen Corp quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2013 to 2024.
  • Repligen Corp Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$833 K, a 25.9% increase year-over-year.
  • Repligen Corp annual Deferred Income Tax Expense (Benefit) for 2023 was $2.32 M.
  • Repligen Corp annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.35 M, a 121% decline from 2021.
  • Repligen Corp annual Deferred Income Tax Expense (Benefit) for 2021 was $6.52 M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$833 K +$291 K +25.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q1 2023 -$1.12 M -$2.17 M -208% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q1 2022 $1.05 M +$256 K +32.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q1 2021 $789 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q1 2019 $892 K +$443 K +98.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $449 K +$439 K +4390% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $10 K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2015 $87 K +$79.4 K +1050% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q1 2014 $7.57 K +$120 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q1 2013 -$112 K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.